1. Home
  2. AVNT vs FOLD Comparison

AVNT vs FOLD Comparison

Compare AVNT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNT
  • FOLD
  • Stock Information
  • Founded
  • AVNT 1927
  • FOLD 2002
  • Country
  • AVNT United States
  • FOLD United States
  • Employees
  • AVNT N/A
  • FOLD N/A
  • Industry
  • AVNT Major Chemicals
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNT Industrials
  • FOLD Health Care
  • Exchange
  • AVNT Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • AVNT 2.9B
  • FOLD 2.5B
  • IPO Year
  • AVNT 1993
  • FOLD 2007
  • Fundamental
  • Price
  • AVNT $30.37
  • FOLD $9.79
  • Analyst Decision
  • AVNT Buy
  • FOLD Buy
  • Analyst Count
  • AVNT 6
  • FOLD 7
  • Target Price
  • AVNT $45.67
  • FOLD $30.29
  • AVG Volume (30 Days)
  • AVNT 789.9K
  • FOLD 5.6M
  • Earning Date
  • AVNT 11-05-2025
  • FOLD 11-04-2025
  • Dividend Yield
  • AVNT 3.57%
  • FOLD N/A
  • EPS Growth
  • AVNT N/A
  • FOLD N/A
  • EPS
  • AVNT 1.23
  • FOLD N/A
  • Revenue
  • AVNT $3,246,100,000.00
  • FOLD $598,704,000.00
  • Revenue This Year
  • AVNT $3.23
  • FOLD $21.12
  • Revenue Next Year
  • AVNT $3.20
  • FOLD $21.23
  • P/E Ratio
  • AVNT $24.62
  • FOLD N/A
  • Revenue Growth
  • AVNT 1.03
  • FOLD 21.28
  • 52 Week Low
  • AVNT $27.48
  • FOLD $5.51
  • 52 Week High
  • AVNT $53.61
  • FOLD $10.57
  • Technical
  • Relative Strength Index (RSI)
  • AVNT 50.96
  • FOLD 64.82
  • Support Level
  • AVNT $27.48
  • FOLD $9.31
  • Resistance Level
  • AVNT $29.56
  • FOLD $10.57
  • Average True Range (ATR)
  • AVNT 1.08
  • FOLD 0.38
  • MACD
  • AVNT 0.11
  • FOLD 0.02
  • Stochastic Oscillator
  • AVNT 72.08
  • FOLD 57.18

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: